Ranked by engagement
Top topics — this month page 2
Ranked by replies, likes and views over this month, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
374 topics · page 2 of 13
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Forced degradation studies: designing one that is informative
Posting this under the heading it deserves: Forced degradation studies: designing one that is informative Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
|
+100 | 106 | 35k | 2d |
|
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile
Posting this under the heading it deserves: Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Everything below is what sits behind that. I have seen SCALE ( N Engl J Med…
|
+115 | 122 | 2.6k | 1d |
|
Common supplements people ask about, assessed one at a time
Common supplements people ask about, assessed one at a time — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same…
|
+101 | 107 | 28k | 12h |
|
A site rotation scheme that is easy enough to actually follow
On the subject in the title: A site rotation scheme that is easy enough to actually follow Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly…
|
+112 | 125 | 5.8k | 21h |
|
Lean mass preservation: what the evidence supports — does this still hold?
Asking directly, because I could not find a straight answer: Lean mass preservation: what the evidence supports — does this still hold? Maintenance rather than loss, which is the part of this that almost…
|
+112 | 122 | 5.2k | 20h |
|
Stepping down deliberately, and how to do it without losing progress — what changed since
Posting this under the heading it deserves: Stepping down deliberately, and how to do it without losing progress — what changed since Everything below is what sits behind that. Practical question with the…
|
+94 | 99 | 29k | 2d |
|
The anatomy of a question that gets answered within an hour
The anatomy of a question that gets answered within an hour — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to include the things…
|
+113 | 127 | 2.7k | 13h |
|
Named, unnamed and unspecified impurities as regulatory categories — the long version
Named, unnamed and unspecified impurities as regulatory categories — the long version — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical…
|
+112 | 120 | 7.6k | 5h |
|
Coming back to: A community side-effect dataset, with its response rate and biases
Posting this under the heading it deserves: A community side-effect dataset, with its response rate and biases Everything below is what sits behind that. Working through the identity arithmetic and I would…
|
+96 | 101 | 33k | 2d |
|
What a reversed-phase purity number actually is
The question in the title: What a reversed-phase purity number actually is I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I repeat…
|
+87 | 101 | 27k | 4h |
|
Prescription portability between countries
Prescription portability between countries — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+104 | 114 | 6.1k | 3h |
|
Journal club: indirect comparison between two programmes, defended and attacked
Journal club: indirect comparison between two programmes, defended and attacked Writing it up because I had to work it out twice and would rather nobody else did. Comparing SUSTAIN 6 ( N Engl J Med , 2016)…
|
+122 | 131 | 5.2k | just now |
|
Molecular mass of semaglutide and why the figure differs between sources
Molecular mass of semaglutide and why the figure differs between sources — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with STEP 4 ( JAMA , 2021)…
|
+101 | 110 | 12k | 16h |
|
CJC-1295 with and without DAC: what the modification does
On the subject in the title: CJC-1295 with and without DAC: what the modification does Working notes rather than a conclusion. Comparing PIONEER 6 ( N Engl J Med , 2019) with SURMOUNT-OSA ( N Engl J Med ,…
|
+117 | 123 | 5.6k | 22h |
|
What a certificate commits its issuer to — one year on
What a certificate commits its issuer to — one year on — that is the question, and I have not found it answered plainly anywhere I have looked. A documentation question rather than an analytical one. I have a…
|
+107 | 117 | 6.5k | 1d |
|
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how quickly…
|
+104 | 114 | 6k | 6d |
|
Rotating between abdomen, thigh and upper arm: absorption differences — one year on
Rotating between abdomen, thigh and upper arm: absorption differences — one year on — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still…
|
+82 | 102 | 24k | just now |
|
Second pass at: Which categories are strict and which are relaxed, honestly
On the subject in the title: Second pass at: Which categories are strict and which are relaxed, honestly Working notes rather than a conclusion. Question in the title. Context below, and I have tried to…
|
+93 | 99 | 36k | 3d |
|
Here for the analytics and not much else
Here for the analytics and not much else — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim. Something…
|
+93 | 102 | 10k | 16h |
|
Private prescribing in the UK: what is actually involved
On the subject in the title: Private prescribing in the UK: what is actually involved Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
|
+66 | 76 | 46k | 14h |
|
Revisiting: What pooling buys you and what it destroys
On the subject in the title: Revisiting: What pooling buys you and what it destroys Working notes rather than a conclusion. Session topic: PIONEER 6 ( N Engl J Med , 2019). Please read it before posting; the…
|
+97 | 107 | 4k | 19h |
|
Reading order for a first week here, and what to skip until later — what changed since
Reading order for a first week here, and what to skip until later — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I want to check my reasoning rather…
|
+89 | 93 | 28k | 4h |
|
[2026 update] Does a peptide degrade silently, with no visual change?
Does a peptide degrade silently, with no visual change? — that is the question, and I have not found it answered plainly anywhere I have looked. I have read the maintained page on this and I still have a gap,…
|
+82 | 86 | 24k | 15d |
|
Tracking intake honestly when appetite is absent
On the subject in the title: Tracking intake honestly when appetite is absent Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a…
|
+109 | 115 | 4.8k | 20h |
|
[2026 update] Antibiotics and a course of something with delayed emptying
On the subject in the title: Antibiotics and a course of something with delayed emptying Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is useful…
|
+88 | 97 | 19k | 13h |
|
Research-use-only status: what it means legally and practically
Research-use-only status: what it means legally and practically Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited in…
|
+72 | 81 | 44k | 1d |
|
Secretagogues and glucose tolerance: the mechanistic concern
On the subject in the title: Secretagogues and glucose tolerance: the mechanistic concern Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
+64 | 70 | 52k | 17d |
|
What I would want from a home test that does not exist yet — what changed since
Asking directly, because I could not find a straight answer: What I would want from a home test that does not exist yet — what changed since Posting the method first, because I know what the first three…
|
+101 | 111 | 1.9k | 21h |
|
Journal club: LEADER as the historical anchor
Journal club: LEADER as the historical anchor Writing it up because I had to work it out twice and would rather nobody else did. Comparing STEP 1 ( N Engl J Med , 2021) with SURMOUNT-4 ( JAMA , 2024) and…
|
+103 | 110 | 8.1k | 2h |
|
GLP-1 receptor distribution: central and peripheral
Posting this under the heading it deserves: GLP-1 receptor distribution: central and peripheral Everything below is what sits behind that. A documentation question rather than an analytical one. I have a…
|
+90 | 98 | 30k | 22h |